TransMedics Group, Inc. — Director's Dealing 2025

Feb 27, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TransMedics Group, Inc. (TMDX)
CIK: 0001756262
Period of Report: 2025-02-25

Reporting Person: Hassanein Waleed H (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-02-25	Common Stock	A	59781	—	Acquired	121424	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-02-25	Stock Option (Right to Buy)	$73	A	90185	Acquired	2035-02-25	Common Stock (90185)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	469359	Indirect

Footnotes

F1: Consists of 59,781 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F2: The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 25, 2025 until the option is fully vested on February 25, 2029, subject to continued service.